文献速递关节外科

肾移植患者翻修关节置换的配对对照队列研究

Revision Joint Arthroplasty and Renal Transplant: A Matched Control Cohort Study.
PubMed 文献 · J Arthroplasty · 2019-08-27

该回顾性Medicare数据库研究纳入2005至2014年1020例肾移植受者(RTR)翻修关节置换(359例翻修全膝、661例翻修全髋),与匹配的非移植翻修患者比较。RTR翻修全膝后住院时间、败血症和1年死亡率升高;RTR翻修全髋后再入院、败血症和1年死亡率升高。RTR翻修最常见的原发诊断为假体机械并发症。

要点

  • RTR翻修全膝后住院时间6.12±7.86天 vs 对照4.33±4.29天,P<.001
  • RTR翻修全膝后败血症OR 2.52(95%CI 1.83-3.46),1年死亡率OR 2.71(95%CI 1.51-4.53)
  • RTR翻修全髋后再入院OR 1.23(95%CI 1.03-1.47),败血症OR 1.82(95%CI 1.41-2.34),1年死亡率OR 2.65(95%CI 1.88-3.66)

核心结论

  • 既往肾移植的翻修关节置换患者较非移植受者合并症发生率和死亡率升高。

研究设计与样本

  • 回顾性Medicare数据库综述,纳入2005至2014年1020例肾移植受者翻修关节置换(359例翻修全膝、661例翻修全髋),并与匹配的非移植翻修关节置换对照组比较。

主要发现

  • RTR翻修全膝后住院时间6.12±7.86天 vs 对照4.33±4.29天(P<.001)。
  • RTR翻修全膝后败血症OR 2.52(95%CI 1.83-3.46,P<.001),1年死亡率OR 2.71(95%CI 1.51-4.53,P<.001)。
  • RTR翻修全髋后再入院OR 1.23(95%CI 1.03-1.47,P=.023),败血症OR 1.82(95%CI 1.41-2.34,P<.001),1年死亡率OR 2.65(95%CI 1.88-3.66,P<.001)。
  • RTR翻修全膝和全髋最常见的原发诊断为假体机械并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is little literature concerning clinical outcomes following revision joint arthroplasty in solid organ transplant recipients. The aims of this study are to (1) analyze postoperative outcomes and mortality following revision hip and knee arthroplasty in renal transplant recipients (RTRs) compared to non-RTRs and (2) characterize common indications and types of revision procedures among RTRs. METHODS: A retrospective Medicare database review identified 1020 RTRs who underwent revision joint arthroplasty (359 revision total knee arthroplasty [TKA] and 661 revision total hip arthroplasty [THA]) from 2005 to 2014. RTRs were compared to their respective matched control groups of nontransplant revision arthroplasty patients for hospital length of stay, readmission, major medical complications, infections, septicemia, and mortality following revision. RESULTS: Renal transplantation was significantly associated with increased length of stay (6.12 ± 7.86 vs 4.33 ± 4.29, P < .001), septicemia (odds ratio [OR], 2.52; 95% confidence interval [CI], 1.83-3.46; P < .001), and 1-year mortality (OR, 2.71; 95% CI, 1.51-4.53; P < .001) following revision TKA. Among revision THA patients, RTR status was associated with increased hospital readmission (OR, 1.23; 95% CI, 1.03-1.47; P = .023), septicemia (OR, 1.82; 95% CI, 1.41-2.34; P < .001), and 1-year mortality (OR, 2.65; 95% CI, 1.88-3.66; P < .001). The most frequent primary diagnoses associated with revision TKA and THA among RTRs were mechanical complications of prosthetic implant. CONCLUSION: Prior renal transplantation among revision joint arthroplasty patients is associated with increased morbidity and mortality when compared to nontransplant recipients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Labaran LA, Amin R, Bolarinwa SA, et al. Revision Joint Arthroplasty and Renal Transplant: A Matched Control Cohort Study. J Arthroplasty. 2019. PMID: 31542264. doi:10.1016/j.arth.2019.08.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。